Literature DB >> 10081504

How intestinal bacteria cause disease.

R L Guerrant1, T S Steiner, A A Lima, D A Bobak.   

Abstract

An improved understanding of how intestinal bacteria cause disease has become increasingly important because of the emergence of new enteric pathogens, increasing threats of drug resistance, and a growing awareness of their importance in malnutrition and diarrhea. Reviewed here are the varied ways that intestinal bacteria cause disease, which provide fundamental lessons about microbial pathogenesis as well as cell signaling. Following colonization, enteric pathogens may adhere to or invade the epithelium or may produce secretory exotoxins or cytotoxins. In addition, by direct or indirect effects, they may trigger secondary mediator release of cytokines that attract inflammatory cells, which release further products, such as prostaglandins or platelet-activating factor, which can also trigger secretion. An improved understanding of pathogenesis not only opens new approaches to treatment and control but may also suggest improved simple means of diagnosis and even vaccine development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081504     DOI: 10.1086/513845

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Regulation of the overlapping pic/set locus in Shigella flexneri and enteroaggregative Escherichia coli.

Authors:  Martin Behrens; Jalaluddin Sheikh; James P Nataro
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

3.  In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation.

Authors:  Amy T Ma; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

Review 4.  Engineered nanoparticles mimicking cell membranes for toxin neutralization.

Authors:  Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2015-04-11       Impact factor: 15.470

Review 5.  Update on Clostridium difficile infection.

Authors:  C S Alcantara; R L Guerrant
Journal:  Curr Gastroenterol Rep       Date:  2000-08

Review 6.  Toxins and the gut: role in human disease.

Authors:  A Fasano
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

7.  Studies on Pongamia pinnata (L.) Pierre leaves: understanding the mechanism(s) of action in infectious diarrhea.

Authors:  S Brijesh; P G Daswani; P Tetali; S R Rojatkar; N H Antia; T J Birdi
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

8.  Newer insights into the mechanism of action of Psidium guajava L. leaves in infectious diarrhoea.

Authors:  Tannaz Birdi; Poonam Daswani; S Brijesh; Pundarikakshudu Tetali; Arvind Natu; Noshir Antia
Journal:  BMC Complement Altern Med       Date:  2010-06-28       Impact factor: 3.659

9.  Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage.

Authors:  S Brijesh; Poonam Daswani; Pundarikakshudu Tetali; Noshir Antia; Tannaz Birdi
Journal:  BMC Complement Altern Med       Date:  2009-11-23       Impact factor: 3.659

10.  An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome.

Authors:  Robin Spiller; Ching Lam
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.